ActualSignal
ActualSignal is a precision health, no-hardware remote monitoring platform that gives neurology clinics and value-based care organizations continuous, objective visibility into Parkinson's patients.
Problem & solution
Parkinson's patients go unmonitored for 99% of their lives between clinic visits, so symptom changes go undetected and snowball into preventable hospitalizations - a $30B+ annual U.S. cost burden. ActualSignal turns the patient's own smartphone into a clinical instrument: computer-vision motor exams, passive sensors and a symptom diary in an app seniors love, combined with care analytics that give clinicians daily, objective visibility and flag deterioration weeks before it occurs.
Primary customers & users
Buyers: neurology and movement-disorder clinics (practice owners, administrators, lead neurologists) and value-based organizations - ACOs, MSOs and Medicare Advantage plans (CMO, VP Population Health). Users: neurologists, PCPs and care managers via the provider dashboard; Parkinson's patients and caregivers via the senior-friendly app.
Differentiation
No wearables - standard smartphone sensors plus proprietary computer vision, in an app seniors actually use (85% monthly engagement). A unique dataset of 120K+ composite patient scores sharpens every assessment. And in a first for neurology, clinics can bill for remote care delivered between visits - a revenue stream ActualSignal uniquely enables.
Current traction
Deployed with hundreds of Parkinson's patients across Florida neurology clinics: 6 paying commercial contracts, $830K contracted ARR, 85% monthly patient engagement. Proprietary dataset of 120,000+ composite patient data scores. Advisory board includes Nicole Bradberry (CEO, Florida Association of ACOs) and senior leaders from Merck and Stanford Medicine. $4M raised to date.
How Summit participants can help
Introductions to neurology service-line and population-health leaders at health systems (HCA, Ascension, LifePoint, Vanderbilt) and to ACO/MA organizations to expand beyond Florida; healthcare investors for our next round; and Nashville operators with experience scaling tech-enabled, value-based care services.